The incidence of transcatheter aortic valve implantation-related heart block in self-expandable medtronic corevalve and balloon-expandable edwards valves

Journal of Invasive Cardiology

Volumn 24, Issue 4, 2012, Pages 173-176

  Liang, Michael ^a,b   Devlin, Gerard ^a   Pasupati, Sanjeevan ^a  

^a WAIKATO HOSPITAL   (New Zealand)

^b NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

AV block; Edwards SAPIEN valve; LBBB; Medtronic CoreValve; pacemaker; TAVI

Indexed keywords

AGED; AORTA STENOSIS; ARTICLE; ATRIOVENTRICULAR BLOCK; CLINICAL ASSESSMENT; ELECTROCARDIOGRAM; FEMALE; HEART BUNDLE BRANCH BLOCK; HEART LEFT BUNDLE BRANCH BLOCK; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; PACEMAKER; RISK ASSESSMENT; TRANSCATHETER AORTIC VALVE IMPLANTATION;

AGED; AGED, 80 AND OVER; AORTIC VALVE; BALLOON DILATION; BUNDLE-BRANCH BLOCK; ELECTROCARDIOGRAPHY; FEMALE; HEART BLOCK; HEART VALVE PROSTHESIS; HEART VALVE PROSTHESIS IMPLANTATION; HUMANS; INCIDENCE; MALE; PACEMAKER, ARTIFICIAL; PROSTHESIS DESIGN; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 84864361371     PISSN: 10423931     EISSN: 15572501     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Ye J, Cheung A, Lichtenstein SV, et al. Transapical transcatheter aortic valve implantation: Follow-up to 3 years. J Thorac Cardiovasc Surg. 2010;139:1107-1113, 1113.e1.
2. Grube E, Schuler G, Buellesfeld L, et al. Percutaneous aortic valve replacement for severe aortic stenosis in high-risk patients using the second- and current third-generation self-expanding corevalve prosthesis: Device success and 30-day clinical outcome. J Am Coll Cardiol. 2007;50(1):69-76. (Pubitemid 46970878)
3. Webb JG, Pasupati S, Humphries K, et al. Percutaneous transarterial aortic valve replacement in selected high-risk patients with aortic stenosis. Circulation. 2007;116(7):755-763. (Pubitemid 47255993)
4. Cribier A, Eltchaninoff H, Tron C, et al. Treatment of calcific aortic stenosis with the percutaneous heart valve: Mid-term follow-up from the initial feasibility studies: The French experience. J Am Coll Cardiol. 2006;47(6):1214-1223.
5. Sinhal A, Altwegg L, Pasupati S, et al. Atrioventricular block after transcatheter balloon expandable aortic valve implantation. JACC Cardiovasc Interv. 2008;1(3):305-309. (Pubitemid 351816793)
6. Jilaihawi H, Chin D, Vasa-Nicotera M, et al. Predictors for permanent pacemaker requirement after transcatheter aortic valve implantation with the CoreValve bioprosthesis. Am Heart J. 2009;157(5):860-866.
7. Boughaleb D, Mansourati J, Genet L, Barra J, Mondine P, Blanc JJ. [Permanent cardiac stimulation after aortic valve replacement: Incidence, predictive factors and long-term prognosis]. Arch Mal Coeur Vaiss. 1994;87(7):925-930. (Pubitemid 24239876)
8. Limongelli G, Ducceschi V, D'Andrea A, et al. Risk factors for pacemaker implantation following aortic valve replacement: A single centre experience. Heart. 2003;89(8):901-904. (Pubitemid 36920817)
9. Bleiziffer S, Ruge H, Horer J, et al. Predictors for new-onset complete heart block after transcatheter aortic valve implantation. JACC Cardiovasc Interv. 2010;3(5):524-530.
10. Criteria comittee, New York Heart Association. Diseases of the heart and blood vessels. Nomenclature and criteria for diagnosis. 1964: P. 114.
11. Epstein AE, DiMarco JP, Ellenbogen KA, et al. ACC/AHA/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: A report of the American College of Cardiology/American Heart Association task force on practice guidelines (writing committee to revise the ACC/AGA/NASPE 2002 guideline update for implantation of cardiac pacemakers and antiarrhythmia devices) developed in collaboration with the American Association for Thoracic Surgery and Society of Thoracic Surgeons. J Am Coll Cardiol. 2008;51(21):e1-e62. (Pubitemid 351689050)
12. Leon MB, Smith CR, Mack M, et al. Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med. 2010;363(17):1597-1607.
13. Piazza N, Onuma Y, Jesserun E, et al. Early and persistent intraventricular conduction abnormalities and requirements for pacemaking after percutaneous replacement of the aortic valve. JACC Cardiovasc Interv. 2008;1(3):310-316. (Pubitemid 351804194)
14. Avanzas P, Munoz-Garcia AJ, Segura J, et al. Percutaneous implantation of the Core-Valve self-expanding aortic valve prosthesis in patients with severe aortic stenosis: Early experience in spain. Rev Esp Cardiol. 2010;63(2):141-148.
15. Erkapic D, Kim WK, Weber M, et al. Electrocardiographic and further predictors for permanent pacemaker requirement after transcatheter aortic valve implantation. Europace. 2010;12(8):1188-1190.
16. Piazza N, Nuis RJ, Tzikas A, et al. Persistent conduction abnormalities and requirements for pacemaking six months after transcatheter aortic valve implantation. EuroIntervention. 2010;6(4):475-484.
17. Eltchaninoff H, Prat A, Gilard M, et al. Transcatheter aortic valve implantation: Early results of the FRANCE (French Aortic National CoreValve and Edwards) registry. Eur Heart J. 2011;32(2):191-197.
18. Bosmans JM, Kefer J, De Bruyne B, et al. Procedural, 30-day and one year outcome following CoreValve or Edwards transcatheter aortic valve implantation: Results of the Belgian national registry. Interact Cardiovasc Thorac Surg. 2011;12(5):762-767.
19. Zahn R, Gerckens U, Grube E, et al. Transcatheter aortic valve implantation: First results from a multi-centre real-world registry. Eur Heart J. 2011;32(2):198-204.
20. Petronio AS, De Carlo M, Bedogni F, et al. Safety and efficacy of the subclavian approach for transcatheter aortic valve implantation with the CoreValve revalving system. Circ Cardiovasc Interv. 2010;3(4):359-366.
21. Thomas M, Schymik G, Walther T, et al. Thirty-day results of the SAPIEN Aortic Bioprosthesis European Outcome (SOURCE) registry: A European registry of transcatheter aortic valve implantation using the Edwards SAPIEN valve. Circulation. 2010;122(1):62-69.
22. Latsios G, Gerckens U, Buellesfeld L, et al. Device landing zone calcification, assessed by msct, as a predictive factor for pacemaker implantation after tavi. Catheter Cardiovasc Interv. 2010;76(3):431-439.
23. Calvi V, Puzzangara E, Pruiti GP, et al. Early conduction disorders following percutaneous aortic valve replacement. Pacing Clin Electrophysiol. 2009;32(Suppl 1):S126-130.
24. Gutierrez M, Rodes-Cabau J, Bagur R, et al. Electrocardiographic changes and clinical outcomes after transapical aortic valve implantation. Am Heart J. 2009;158(2):302-308.